« Back
Home /
LY2157299 (Galunisertib)

LY2157299 (Galunisertib)

Item no.	M1980-5mg
Manufacturer	AbMole
CASRN	700874-72-2
Amount	5mg
Category	Oncology Neuroscience Neural Lineage Markers Molecular Targets for Neuroscience Inhibitors & Compound Libraries Small Molecules By Organ Bladder Cancer Bone Cancer Neurodegeneration Markers
Type	Inhibitors
Specific against	other
Purity	0,9956
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	Galunisertib
Similar products	LY2157299
Available
Target Information	TGF-β Receptor
Molecular Weight	369, 42
Solubility	DMSO 80 mg/mL
Bioactivity information	LY2157299 (Galunisertib) is a novel clinically relevant TBRI (ALK5 kinase) inhibitor with IC50 of 56 nM.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

M1980-5mg-safety-datasheet.pdf